Contraline's last reported valuation, Feb 2025. Nothing priced has surfaced since.
- ·The complete investor list: 52 names
- ·Watch Contraline: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Contraline funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2026 | Later Stage VC | $55.8M | ▮ | ▮ |
| Apr 2022 | Later Stage VC | $7.2M | ▮ | ▮ |
| Oct 2021 | Later Stage VC (Series A1) | $16.0M | ▮ | ▮ |
Membership and data by Private Market View
Contraline valuation
Contraline's last reported valuation was $60 million in Feb 2025. No priced round, secondary trade or fund mark has surfaced since.
How much has Contraline raised?
Contraline has raised $41.7 million across 3 recorded rounds since 2021. The largest was a $7.2 million later-stage round in Apr 2022; the most recent was a $55.8 million later-stage round in May 2026.
Contraline has filed 1 Form D with the SEC, most recently in Apr 2022 ($7.2 million sold to 22 investors).
Institutional holders and vehicles
In the last 12 months, 3 investment vehicles were formed to buy Contraline shares, reporting $2.3 million sold to 106 investors across 3 sponsors, per SEC Form D filings (most recent Jun 2026).
Comparable companies
Comparable drug discovery names by valuation on PrivateMarketView: Pangea Bio ($80 million), Parallel Bio ($71.5 million) and Hinge Bio ($46 million).
How Contraline's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Contraline, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Contraline
- What is Contraline worth?
- Contraline is valued at $60.0M as of Oct 2026. Contraline's last reported valuation, Feb 2025. Nothing priced has surfaced since.
- How much has Contraline raised?
- Contraline has raised $41.7M in total funding across 3 recorded rounds.
- When did Contraline last raise?
- Contraline last raised in May 2026 (Later Stage VC), raising $55.8M.